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ABSTRACT
Altered cortical excitability and synapse dysfunction are early
pathogenic events in amyotrophic lateral sclerosis (ALS) patients
and animal models. Recent studies propose an important role for TAR
DNA-binding protein 43 (TDP-43), the mislocalization and aggregation
of which are key pathological features of ALS. However, the
relationship between ALS-linked TDP-43 mutations, excitability and
synaptic function is not fully understood. Here, we investigate the role
of ALS-linked mutant TDP-43 in synapse formation by examining the
morphological, immunocytochemical and excitability profile of
transgenic mouse primary cortical pyramidal neurons that over-
express human TDP-43A315T. In TDP-43A315T cortical neurons,
dendritic spine density was significantly reduced compared to
wild-type controls. TDP-43A315T over-expression increased the total
levels of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropinionic acid
(AMPA) glutamate receptor subunit GluR1, yet the localization of
GluR1 to the dendritic spine was reduced. These postsynaptic
changes were coupled with a decrease in the amount of the
presynaptic marker synaptophysin that colocalized with dendritic
spines. Interestingly, action potential generation was reduced in
TDP-43A315T pyramidal neurons. This work reveals a crucial effect
of the over-expression mutation TDP-43A315T on the formation of
synaptic structures and the recruitment of GluR1 to the synaptic
membrane. This pathogenic effect may be mediated by cytoplasmic
mislocalization of TDP-43A315T. Loss of synaptic GluR1, and reduced
excitability within pyramidal neurons, implicates hypoexcitability
and attenuated synaptic function in the pathogenic decline of
neuronal function in TDP-43-associated ALS. Further studies into
the mechanisms underlying AMPA receptor-mediated excitability
changes within the ALS cortical circuitry may yield novel therapeutic
targets for treatment of this devastating disease.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is the most common form of
adult-onset motor neuron disease. In ALS, the degeneration of
cortical and spinal motor neurons results in loss of voluntary
movement, progressive muscle paralysis and ultimately death
within 2-5 years of diagnosis (Talbot, 2014; Zufiria et al., 2016).
This disease is predominately sporadic, with only 10% of
cases due to familial inheritance of an autosomal dominant
mutation in genes such as SOD1, C9orf72, FUS or TARDBP
(Kiernan et al., 2011; Renton et al., 2014). Similarities in
pathological hallmarks and the clinical progression of both
sporadic and familial forms of ALS have led to the suggestion of
a commonality in the final neurodegenerative pathway. In recent
years, this theory has extended to observations of altered
excitability. Clinical electrophysiological studies have identified
the phenomenon of cortical hyperexcitability in sporadic and
familial forms of ALS, preceding both the onset of clinical
symptoms and measurable lower motor neuron dysfunction in
patients (reviewed by Geevasinga et al., 2016). This suggests that
imbalances in motor cortex excitation are one of the earliest
pathological events in the disease (Fogarty, 2018). Furthermore,
cortical hyperexcitability may propagate through the corticomotor
system (Menon et al., 2015; Eisen et al., 1993; Vucic et al., 2013),
leading to degeneration of lower motor neurons. Yet clinical,
animal model and human induced pluripotent stem cell (iPSC)
studies now indicate that excitability alterations in ALS are a
complex and evolving sequence of events, potentially involving
both hyperexcitability and hypoexcitability of various neuron and
interneuron populations that make up the cortical circuitry and
varying at different disease stages (Clark et al., 2015; Geevasinga
et al., 2016; Leroy and Zytnicki, 2015; White et al., 2018).
In 2006, transactive response DNA-binding protein 43 (TDP-43)
was recognized as the primary protein component of intracellular
ubiquitinated inclusions in the majority of ALS cases and a subset of
frontotemporal lobar degeneration (FTLD) cases (Neumann et al.,
2006; Geser et al., 2010). Mutations in the TARDBP gene, which
encodes TDP-43, such as that resulting in an alanine to threonine
amino acid substitution (TDP-43A315T), were identified in familial
forms of ALS (Neumann et al., 2006). Mislocalized or mutant
TDP-43 is suspected to play a major role in ALS pathogenesis
(Buratti and Baralle, 2008; Sreedharan et al., 2008; Yokoseki et al.,
2008), yet it is unclear how TDP-43 dysfunction or mutation is
linked to altered cortical excitability. TDP-43 is thought to play a
role in the synaptic connections of lower motor neurons; it is
localized to the neuromuscular junction (NMJ) in mice (Narayanan
et al., 2013) and is required for the development and locomotor
function of the NMJ in Drosophila (Estes et al., 2011; Estes et al.,
2013; Feiguin et al., 2009; Li et al., 2010). Mutation or expression
modulation of TDP-43 also leads to impaired locomotor function
and NMJ disturbances in Caenorhabditis elegans (Ash et al., 2010)
and Danio rerio (Armstrong and Drapeau, 2013; Kabashi et al.,
2010; Schmid et al., 2013). Interestingly, calcium channel agonists
rescue this phenotype in mutant TDP-43 zebrafish, indicating that
disruption to synaptic homeostasis plays a key role in theReceived 15 November 2018; Accepted 12 April 2019
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pathogenesis of mutated TDP-43 at this distal site (Armstrong and
Drapeau, 2013).
However, little is known about the effect of mutant TDP-43 on
excitability in upper motor neurons. Motor neurons derived from
iPSCs carrying a TDP-43 mutation demonstrate a hyperexcitable
phenotype that switches to hypoexcitability as the neurons mature
(Devlin et al., 2015), and we previously demonstrated synaptic
disturbances in the motor cortex occur early in a mouse model
that expresses human TDP-43A315T (Handley et al., 2017).
To determine the effect of mutant TDP-43 on the development
and formation of synapses in upper motor neurons in vitro,
we derived primary cortical neuronal cultures from transgenic
mouse embryos expressing human TDP-43A315T under the Prp
promoter (Wegorzewska et al., 2009) and yellow fluorescent protein
(YFP) in cortical pyramidal/projection neurons under the Thy1
promoter (Feng et al., 2000). We examined neuronal process
structure, dendritic spine density, synaptic protein localization
and electrophysiological excitability. This study identified that
ALS-linked mutant TDP-43 (A315T mutation) has a significant
pathological influence on synapse development in pyramidal
cortical neurons by acting on the formation of the ionotropic
glutamate receptors.
RESULTS
TDP-43A315Texpression does not significantly affect cortical
neuron dendrite or axon outgrowth, but reduces dendritic
arbor complexity
Synaptic loss is a major feature of neurodegenerative disorders,
and to begin examining the effect of mutant TDP-43 on excitability
we first examined the effect of TDP-43A315T expression on the
outgrowth of axons and dendrites, on which the pre- and
postsynaptic compartments are located, respectively. YFP:TDP-
43A315T primary cortical neuron cultures were derived from single
transgenic embryos. TDP-43A315T expression was detected with an
antibody specific to human TDP-43 (hTDP-43). To confirm which
cells expressed hTDP-43, we immunostained and quantified cells
double-labeled for neuronal and glial markers (Fig. 1). There were
significantly more YFP-positive and MAP2-positive neurons with
TDP-43A315T expression than GFAP and DAPI positive cells
[Fig. 1A,B; F(3,51)=68.84, P<0.0001, two-way ANOVA]. Very
few GFAP-positive cells (astrocytes) were positive for hTDP-43
(Fig. 1B), confirming the neuronal expression of TDP-43A315T in
this model. To investigate the subcellular localization of mutant
TDP-43A315T, cytoplasmic and nuclear extractions were performed
at 15 days in vitro (DIV) (Fig. 1). TDP-43A315T was predominately
located in the nuclei of YFP:TDP-43A315T cells (Fig. 1C,D);
however, cytoplasmic localization was also observed (Fig. 1C,E).
Negligible hTDP-43 was detected in the cytoplasmic and nuclear
compartments of YFP:wild-type (WT) cells, which highlights the
specificity of the hTDP-43 antibody to the hTDP-43A315T protein
and confirming expression of hTDP-43A315T in the cortical neuron
culture model (Fig. 1C-E). Disease models using TDP-43 knockout
display significant alterations to the complexity of the lower motor
neuron presynaptic terminal (Feiguin et al., 2009) and TDP-43 is
localized and actively transported in vivo in motor neuron axons
(Fallini et al., 2012). To investigate the effects of TDP-43A315T on
cortical axon outgrowth during neuronal development, cortical
neurons from WT and TDP-43A315T embryos were cultured in
microfluidic chambers (Southam et al., 2013), which allows
selective analysis of axons (Fig. 1F-H). There were no significant
changes between YFP:WT and YFP:TDP-43A315T neurons in total
axon length or axon path length (Fig. 1I,J).
Next, we investigated whether TDP-43A315T affected dendrite
development. To investigate dendrite outgrowth, using MAP2
immunoreactivity we measured the total dendrite length, mean
dendrite length, dendritic branch number and dendritic branch order
in YFP:WT and YFP:TDP-43A315T neurons at 3, 5, 10 and 15 DIV
(Fig. 2A). Total dendrite length significantly increased over time
[F(3,43)=24.31, P<0.0001, two-way ANOVA], with greater total
dendrite length at 15 DIV compared to 3 DIV in both YFP:WT and
YFP:TDP-43A315T neurons (YFP:WT, P<0.0001; YFP:TDP-
43A315T, P<0.001; Tukey’s multiple comparisons test) (Fig. 2A).
There was no significant difference in total dendrite length between
YFP:WT and YFP:TDP-43A315T cortical neurons at any time point
analyzed (Fig. 2B). Similarly, mean dendrite length significantly
increased over time [F(3,43)=25.71, P<0.0001, two-way ANOVA],
with greater mean length at 15 DIV compared to 3 DIV in both YFP:
WT and YFP:TDP-43A315T neurons (YFP:WT, P<0.0001; YFP:
TDP-43A315T, P<0.001; Tukey’s multiple comparisons test), but
there was no significant difference in mean dendrite length between
YFP:WT and YFP:TDP-43A315T cortical neurons at any time point
(Fig. 2C). To investigate dendrite complexity, the number of
dendrite branches was quantified. There was no significant
difference in dendritic branch number between YFP:WT and
YFP:TDP-43A315T neurons at any time point (Fig. 2D).
Quantification of the number of primary (1°), secondary (2°),
tertiary (3°) and quaternary (4°) dendrite branches at 3, 5, 10, and 15
DIV demonstrated that YFP:TDP-43A315T neurons were less
complex, with significantly fewer quaternary branches than YFP:
WT neurons at 15 DIV (Fig. 2E) (P<0.05, Tukey’s multiple
comparisons test after two-way ANOVA).
TDP-43A315T significantly reduces dendritic spine density in
cortical neurons
Dendritic spines are under constant turnover and morphological
modification dependent on stimuli, environment and location; these
capacities are key for neuronal connectivity and synaptic plasticity
(Sala and Segal, 2014; Fiala et al., 2002). TDP-43 may have a role in
the generation and maturation of dendritic spines, shown from in vitro
studies using hippocampal neurons (Majumder et al., 2012; Wiens
et al., 2005). Furthermore, we have shown that mutated TDP-43A315T
has a significant pathological effect on dendritic spine morphology
and excitability in the motor cortex in vivo (Handley et al., 2017). To
establish whether changes to dendritic spine density are present in an
isolated cortical system in vitro similar to those found in the motor
cortex in vivo, primary cortical neurons derived from YFP:TDP-
43A315T embryos were grown to 10 and 15 DIV. YFP:WT and YFP:
TDP-43A315T cortical neurons develop extensive dendritic spines by
10 and 15DIV (Fig. 3A, inset). Spine density was increased by time in
culture [F(1,45)=41.71, P<0.0001, two-way ANOVA] but decreased
when the mutant TDP-43A315T was expressed [F(1,45)=21.23,
P<0.0001, two-way ANOVA], with a significant reduction in spine
density in YFP:TDP-43A315T neurons compared to YFP:WT controls
at both 10 DIV and 15 DIV (10 DIV, P<0.05; 15 DIV, P<0.01;
Tukey’s multiple comparisons test) (Fig. 3B). This result indicates that
loss of spine density is a dendrite-specific consequence of over-
expression of human TDP-43 with the TDP-43A315T mutation in our
in vitro cortical neurons, and occurs independently of any gross
changes in dendrite and axon development.
TDP-43A315T mutation alters of the expression of synaptic
proteins in cortical neurons
To determine whether TDP-43A315T-mediated spine loss is
associated with alterations in the expression of postsynaptic
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proteins, colocalization betweenGFP (endogenousYFP fluorescence
enhanced by anti-GFP antibody; denoted as GFP) and glutamate
receptor subunits [GluR1 (also known as Gria1), GluR2 (Gria2) and
GluR4 (Gria4)] or postsynaptic density marker PSD-95was analyzed
inYFP:WTandYFP:TDP-43A315T cortical neurons grown to 10DIV
(Fig. 4). The glutamate receptor subunit GluR1 was significantly
increased in the YFP:TDP-43A315T neurons (Fig. 4A,B) [t(4)=4.450,
P=0.0112, t-test]. There was no significant difference in GluR2,
GluR4 and PSD-95 in the YFP:TDP-43A315T neurons in comparison
to the YFP:WT controls (Fig. 4C-H).
To investigate whether this change in the amount of GluR1
subunit affected its incorporation into AMPA receptors at the
synapse, the presence of surface GluR1 in dendritic spines was
investigated with an antibody against the extracellular N-terminal
domain (NT-GluR1) in non-permeabilized neurons (Fig. 5).
NT-GluR1 colocalized with the presynaptic marker synaptophysin
in GFP-positive dendritic spines in YFP:WT neurons (Fig. 5A,
arrowheads). However, in YFP:TDP-43A315T neurons the presence
of colocalized NT-GluR1 and synaptophysin within GFP-positive
spines was reduced (Fig. 5B, arrows). GFP and NT-GluR1
Fig. 1. Human TDP-43A315T (hTDP-43A315T) expression in primary cortical neurons. (A) Immunocytochemistry of YFP (green), hTDP-43 (red), GFAP (blue)
and DAPI (yellow) in YFP:TDP-43A315T cortical cultures at 10 DIV (n=3 biological replicates). (B) Quantification of the number of DAPI, YFP, MAP2 and
GFAP cells positive for hTDP-43 demonstrated that ∼50% of DAPI positive cells were hTDP-43-positive, whereas ∼100% of YFP and MAP2 cells and very
few GFAP cells were positive for hTDP-43. (C) Western blot of nuclear and cytoplasmic extractions of 15 DIV YFP:TDP-43A315T cortical cultures. TDP-43A315T,
detected with the antibody specific to hTDP-43, was predominately located in the nuclei of YFP:TDP-43A315T cells; however, cytoplasmic localization was
also observed. No hTDP-43 was detected in the cytoplasmic and nuclear compartments of YFP:WT cells, highlighting the specificity of the hTDP-43 antibody to
the hTDP-43A315T protein and confirming expression of hTDP-43A315T in our cortical neuron culture model. (D) Quantification of hTDP-43 in 5 µg of cytoplasmic
(Cy) and nuclear (Nu) protein fractions confirmed the specificity of hTDP-43 over-expression in TDP-43A315T cortical neurons, and showed that cytoplasmic
levels of hTDP-43 were∼2% those of nuclear levels, with only negligible/background signal detected in WT neurons. (E) hTDP-43 was detected strongly in 20 µg
of cytoplasmic protein from TDP-43A315T neurons, with WT neurons showing negligible signal. (F) The microfluidic chamber culture platform isolates axons
in the distal compartment from cell bodies in the proximal compartment. (G,H) Live microscopy images for axonal growth cones (inset) were captured at 6 DIV.
(I,J) Tracking of total axon outgrowth and path length demonstrated no significant changes between YFP:WT and YFP:TDP-43A315T neurons (n=99 axons
and n=87 axons, respectively, altogether from three biological replicates). *P<0.05 (two-way ANOVA with Tukey’s multiple comparisons test). Data are
mean±s.e.m. Scale bars: 20 μm.
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colocalization at 10 DIV demonstrated there was a significant
decrease of the ratio of NT-GluR1 to GFP in the TDP-43A315T
neurons (Fig. 5C) [t(4)=3.848, P=0.0183, t-test]. The ratio of NT-
GluR2 to GFP in YFP:WT and YFP:TDP-43A315T neurons was not
different (Fig. 5D), indicating a selective decrease of GluR1 AMPA
receptor subunits at the postsynapse. Quantification of the ratio of
presynaptic protein synaptophysin to GFP demonstrated significant
decrease in the overall colocalization of synaptophysin to GFP in
YFP:TDP-43A315T cortical neurons in comparison to YFP:WT
controls [t(4)=4.809, P=0.0086, t-test] (Fig. 5E). Despite its lower
overall presence, accumulations of synaptophysin were frequently
observed in YFP:TDP-43A315T dendrites, and quantification of the
size of synaptophysin-immunoreactive particles confirmed a
significant increase in the area of synaptophysin puncta in the
YFP:TDP-43A315T neuronal network in comparison to YFP:WT
controls [F(1,74)=16.30, P=0.001, two-way ANOVA] with no
change in NT-GluR1 particle area (Fig. 5F). This data indicates that
despite increased overall levels of GluR1, TDP-43A315T causes a
decrease in the localization of GluR1 to the synapse and
accumulation of synaptophysin at the presynaptic site, potentially
driving a reduction in excitability in TDP-43A315T cortical neurons.
TDP-43A315T mutation leads to hypoexcitability in cortical
neurons
To determinewhether the decrease in spine density reflects a decrease
in synaptic transmission, we examined the electrophysiological
properties of YFP:WT and YFP:TDP-43A315T neurons in vitro at 10
DIV. YFP-positive neurons were used to make whole-cell patch
clamp recordings (Fig. 6A,B). There were no significant differences
in resting membrane potential (Fig. 6C), capacitance (Fig. 6D) and
input resistance (Fig. 6E) between YFP:WT and YFP:TDP-43A315T
cortical neurons. However, there was a significant increase in
depolarization threshold in the YFP:TDP-43A315T cortical neurons in
comparison to YFP:WT controls [t(18)=2.865, P=0.0103, t-test]
Fig. 2. The effect of TDP-43A315T expression on dendrite development. (A) Primary cortical neurons derived from YFP:WT (left) and YFP:TDP-43A315T (right)
single embryo cultures labeled for MAP2 at 3 DIV, 5 DIV, 10 DIV and 15 DIV. (B) Total dendrite length significantly increased between 3 and 15 DIV in both
WT and TDP-43A315T cultures. There was no significant difference in total dendrite length between WT and TDP-43A315T at any time point. (C) Mean dendrite
length significantly increased between 3 and 15 DIV in both WT and TDP-43A315T cultures. There was no significant difference in mean dendrite length
between WT and TDP-43A315T at any time point. (D) There was no significant difference in dendritic branching number between 3 and 15 DIV in both WT
and TDP-43A315T cultures. There was no significant difference in dendritic branching number between WT and TDP-43A315T neurons at any time point.
(E) Quantification of the number of primary (1°) secondary (2°) tertiary (3°) and quaternary (4°) dendrite branches at 3, 5, 10 and 15 DIV demonstrated that
TDP-43A315T neurons became significantly less complex in quaternary branches by 15 DIV. n=3 biological replicates. *P<0.05 (two-way ANOVA with
Tukey’s multiple comparisons test). Data are mean±s.e.m. Scale bars: 20 μm.
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(Fig. 6F). There were no significant differences in peak inward
current (Fig. 6G) or peak outward current (Fig. 6H). The relationship
between firing frequency and injected current (the f-I function) was
also assessed to study the net excitability of cortical neurons with the
TDP-43A315T mutation. Using a series of depolarizing current steps
(100 to 500 pA, in 25 pA increments, 200 ms duration), the f-I
relationship that was generated indicated that the YFP:TDP-43A315T
neurons fired at lower rates for a given current compared to YFP:WT
neurons (Fig. 6I). Despite similar passive membrane properties, YFP:
TDP-43A315T neurons fired significantly fewer action potentials
during depolarization than YFP:WT neurons. Overall, these results
indicate that the loss of GluR1 and concurrent loss of dendritic
spines correlates to a decreased excitability of cortical pyramidal
neurons in vitro.
DISCUSSION
ALS is characterized by the progressive loss of motor neurons in
the brain and spinal cord, with TDP-43 protein aggregation a
consistent pathological hallmark. Changes in cortical excitability,
and anterograde propagation of excitotoxicity through the motor
system, are increasingly recognized as an important feature of ALS
pathogenesis. Herein, we describe the alterations at the synapse of
cortical pyramidal neurons caused by the A315T mutation in
TDP-43. We demonstrate that dendritic spine density is significantly
attenuated by the over-expression of human TDP-43A315T, preceding
alteration in dendritic arbor complexity. Interestingly, despite
upregulation of total GluR1, TDP-43A315T causes a decrease in
the localization of GluR1 to the synapse and accumulation of
synaptophysin at the presynaptic site, with these synaptic alterations
potentially driving the observed reduction in excitability in
TDP-43A315T cortical neurons. Together, these results provide a
putative novel mechanistic link between mutation in TDP-43 and
neuronal dysfunction in ALS.
Previous studies of pathogenic TDP-43 on dendritic and axonal
structural integrity have yielded varying results. TDP-43 protein
expression is autoregulated (Avendano-Vazquez et al., 2012; Ayala
et al., 2011), and both over-expression and under-expression of
TDP-43 can lead to selective neuronal vulnerability (Majumder
et al., 2012). The manipulation of endogenous TDP-43 and WT
hTDP-43 affects neurite outgrowth in different types of mammalian
central nervous system neurons, and in the Drosophila peripheral
nervous system (Yang et al., 2010; Fiesel et al., 2011; Iguchi et al.,
2009; Liu-Yesucevitz et al., 2014; Fallini et al., 2012). In the present
study, using a transgenic model of stable TDP-43A315T expression,
we found no significant changes in dendrite or axonal outgrowth.
The absence of axonal outgrowth observed may be specific to
cortical neurons, as previous studies in lower motor neurons have
shown that mutant TDP-43 has a prominent effect on axons (Fallini
et al., 2012). This suggests that the effect of TDP-43 over-
expression and/or mutant TDP-43 may depend upon cell type.
Interestingly, plasmid-mediated expression of mutant TDP-43A315T,
TDP-43Q331K or TDP-43M337V in differentiated cortical neurons
regulated overall neurite morphology relative to TDP-43WT (Han
et al., 2013). When investigating dendrite development through the
branching order of dendrites, we found a loss of complexity by 15
DIV. Loss of dendrite arbor complexity can have dire effects on
neuronal connectivity and has been shown to occur in
neurodegenerative diseases such as Alzheimer’s disease
(Dorostkar et al., 2015). Our results demonstrate that, when
identifying dendrites and axons separately, the TDP-43A315T
mutant specifically affects the structure of the dendritic arbor,
potentially affecting the ability of TDP-43A315T cortical neurons to
receive and integrate incoming synaptic transmissions.
In hippocampal neurons, TDP-43 has been identified as a negative
regulator of dendritic spine density (Majumder et al., 2012), acting
together with Fragile X Syndrome protein FMRP to co-repress the
translation of Rac1 mRNA (Majumder et al., 2016). Activation of the
Rac1 pathway stabilizes dendritic spines and recruits AMPA
receptors to the postsynaptic membrane, enhancing excitatory
synaptic transmission (Wiens et al., 2005; Majumder et al., 2012).
Consistent with a potential reduction in Rac1-mediated AMPA
recruitment, in the present study we identified a loss of GluR1 at the
postsynapse in TDP-43A315T cortical neurons. The reduction of
GluR1 at the postsynapsemay result in attenuated receptivity of TDP-
43A315T cortical pyramidal neurons to glutamatergic inputs from
surrounding neuronal cells, resulting in reduced excitability.
However, we also identified an overall increase in GluR1 in the
cytoplasm. Therefore, the changes observed indicate that either an
overall increase in TDP-43 in the cytoplasm and synaptic
compartments differentially affects the GulR1 regulation at the
synapse, or that mutant TDP-43 may be producing a form of GluR1
that is less effective at being incorporated into the postsynapse
membrane. The latter is plausible, as mutations in TDP-43 are known
to affect its splicing function (White et al., 2018; Arnold et al., 2013).
Furthermore, White et al. (2018) demonstrated with a TDP-43Q331K
knock-in mouse model that altered RNA splicing function may be
due to a gain of TDP-43 function that has resulted from perturbed
autoregulation.
Alterations in excitability are thought to play a key role in the
pathogenesis of ALS. Clinical findings of cortical hyperexcitability
(Eisen et al., 1993; Vucic et al., 2008; Bae et al., 2013), along with
the prescribed ALS therapeutic agent Riluzole that is thought to act
Fig. 3. The effect of TDP-43A315T expression on dendrite spine
development. (A) YFP:WT and YFP:TDP-43A315T cortical neurons at 15 DIV
develop extensive dendritic spines (boxed areas, enlarged in insets).
(B) Quantification demonstrated a significant increase in spine density
between 10 and 15 DIV in both WT and TDP-43A315T cortical neurons.
There was a significant reduction in spine density in the TDP-43A315T neurons
at both 10 and 15 DIV in comparison to WT controls. n=3 biological
replicates. *P<0.05 (two-way ANOVA with Tukey’s multiple comparisons
test). Data are mean±s.e.m. Scale bar: 50 μm; 20 μm in inset.
5
RESEARCH ARTICLE Disease Models & Mechanisms (2019) 12, dmm038109. doi:10.1242/dmm.038109
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
in part by dampening glutamatergic signaling (Doble, 1996),
support the hypothesis of anterograde glutamate-mediated
excitotoxicity as a primary cortical pathogenic origin for the
disease (Eisen et al., 1993). Indeed, our previous research has shown
the vulnerability of lower motor neurons to excitotoxicity (Blizzard
et al., 2015; King et al., 2007). Pre-symptomatic cortical
hyperexcitability can be detected not only in patients with ALS
(Vucic et al., 2008;Menon et al., 2015), but also in pre-symptomatic
SOD1G93A and TDP-43Q331K transgenic mouse models of disease
(Kuo et al., 2004; Martin et al., 2013; Fogarty et al., 2015; Saba
et al., 2015; Carunchio et al., 2010; Pieri et al., 2003; van Zundert
et al., 2008; Fogarty et al., 2016). Synaptic GluR1 levels have
previously been reported as increased in spinal cord motor neurons
before disease onset in the human SOD1G93A (hSOD1G93A) mouse
(Zhao et al., 2008), initially suggesting that the increase could lead
to subsequent glutamate-mediated excitotoxicity and ALS-like
pathology. However, subsequent studies in the hSOD1G93A mouse
model showed that: disease-resistant motor neurons display early
intrinsic hyperexcitability (Leroy et al., 2014); this hyperexcitability
was absent from the adult spinal motor neurons (Delestrée et al.,
Fig. 4. The effect of TDP-43A315T expression on synaptic receptor expression. (A-H) YFP:WT and YFP:TDP-43A315T primary cortical neurons at 10 DIV
were labeled for postsynaptic receptors and GFP (antibody against GFP enhances endogenous YFP fluorescence). Immunocytochemistry labeling for the
glutamate receptor subunits (red, first column) GluR1 (A), GluR2 (C) and GluR4 (E) and the postsynaptic protein PSD-95 antibody (G), and GFP antibody
(green, second column); colocalization (black, third column) was identified in ImageJ and overlaid onto GFP fluorescence images (white; fourth column).
(B,D,F) The ratio of GluR1 to GFP was significantly increased (B), whereas there was no significant differences in the ratio of GluR2 to GFP (D) and GluR4
to GFP (F) in the TDP-43A315T neurons in comparison to WT controls. (H) There was no significant difference in the ratio of PSD-95 to GFP in the
TDP-43A315T neurons in comparison to WT controls. n=3 biological replicates. *P<0.05 (Student’s t-test). Data are mean±s.e.m. Scale bar: 10 μm.
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2014) and was not present in vulnerable motor neuron populations
at disease endstage (Fuchs et al., 2013); the inhibition of pre-
symptomatic motor neuron excitability accelerated disease
progression (Saxena et al., 2013). These later studies support a
case for hypoexcitability to be the pathogenic mechanism in ALS.
Our data may identify how AMPA receptor-mediated changes
contribute to this. Specifically, in agreement with the earlier studies,
we show an overall increase in GluR1 subunit, suggesting a
potential increase in excitability. However, our surface receptor and
functional studies have also identified that, although GluR1
expression may be increased, its vital localization to the
postsynaptic membrane is decreased, with an overall decrease in
excitability. Therefore, we have identified that the pathogenic
cascade that is initiated by hypoexcitability in ALS may be
occurring at the postsynaptic AMPA receptor.
The advent of iPSC studies has provided some clarity over
whether patient-derived neurons display an intrinsic excitability
alteration. At early time points in culture, motor neurons derived
from SOD1-ALS, C9ORF72-ALS and FUS-ALS patients showed
hyperexcitability (Wainger et al., 2014), whereas a separate study
showed motor neurons derived from C9ORF72-ALS patients
exhibited hypoexcitability at a later time point in culture (Sareen
et al., 2013). Subsequently, it was shown that motor neurons derived
from TARDBP-ALS and C9ORF72-ALS patients demonstrated an
initial phase of hyperexcitability, followed by a progressive loss of
both action potential output and synaptic activity (Devlin et al.,
2015). This shift from a hyperexcitable phenotype to a
hypoexcitable phenotype, although potentially representing both
initiating factors and compensatory mechanisms, indicates that the
transition towards hypoexcitability may be a key feature in the
pathogenic decline of motor neurons. The data from our current
study demonstrates hypoexcitability mediated by TDP-43A315T in
10 DIV cortical pyramidal neurons. Although it is difficult to
determine the stage of disease in ALS patients to which cultured
primary neurons correspond, and investigation of earlier or later
time-points is technically fraught because of the nature of primary
rodent neurons in vitro, the hypoexcitable phenotype we report here
may correspond to that noted in iPSC-derived neurons maintained
in culture over an extended period of time (Devlin et al., 2015;
Sareen et al., 2013). Furthermore, although we found changes in
depolarization threshold related to the mutation, there were no
alterations in input resistance. Changes in action potential threshold
are often, but not always, related to changes in the input resistance
of a neuron. This is because spike threshold as measured at the
soma is also dependent on the active properties of the membrane,
and because it happens at the axonal initial segment, many other
variables can have an effect, such as the density and spatial
distribution of voltage-gated sodium and potassium channels in the
initial axon segments and the presence and extent of dendritic
action potentials (Goldwyn and Shea-Brown, 2011; Platkiewicz
and Brette, 2010; Platkiewicz and Brette, 2011; Yi et al., 2015).
The specific involvement of any of these factors in the
electrophysiological changes found in the TDP-43 neurons would
need to be further investigated.
In the present study, we have identified that TDP-43A315T cortical
projection neuron hypoexcitability was associated with loss of the
AMPA receptor subunit GluR1 at the dendritic spine. Interestingly,
enhancing excitability within a vulnerable motor neuron population
in hSOD1G93A mice was neuroprotective to the point of reversing
disease pathology (Saxena et al., 2013). As such, a carefully
targeted therapy designed to increase the incorporation of GluR1
subunits into the postsynaptic membrane in cortical projection
Fig. 5. The effect of TDP-43A315T expression at the synapse.
(A) Immunocytochemistry for NT-GluR1 (blue), synaptophysin (Syn, red)
and GFP (green) demonstrated that NT-GluR1 and synaptophysin colocalized
at the dendritic spine (white) in YFP:WT dendrites (A, arrowheads). (B) In
YFP:TDP-43A315T dendrites, immunocytochemistry for NT-GluR1 (blue),
synaptophysin (red) and GFP (green) demonstrated that spines were
present that colocalized for NT-GluR1 and synaptophysin (white;
arrowhead), with spines also present lacking NT-GluR1 (arrows); frequent
accumulations of synaptophysin were observed outside the identified
dendritic spines. (C) Quantification of the ratio of NT-GluR1 to GFP
demonstrated significant decrease in the colocalization of NT-GluR1 in
TDP-43A315T cortical neurons in comparison to WT controls. (D) Quantification
of the ratio of NT-GluR2 to GFP demonstrated no significant change in the
ratio of colocalization of NT-GluR2 in TDP-43A315T cortical neurons in
comparison to WT controls. (E) Quantification of the ratio of synaptophysin
to GFP showed significant decrease in the colocalization of synaptophysin in
TDP-43A315T cortical neurons in comparison to WT controls. (F) Quantification
of the particle size of NT-GluR1 and synaptophysin demonstrated that
there was a significant increase in the area of the synaptophysin particles
in TDP-43A315T cortical neurons in comparison to WT controls. n=3
biological replicates. *P<0.05 (Student’s t-test and two-way ANOVA
with Tukey’s multiple comparisons test). Data are mean±s.e.m. Scale
bars: 1 μm.
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neurons may be successful in restoring appropriate cortical neuron
excitability in these particular cells. However, further research into
temporal and cell-type-specific changes in excitability in ALS
cortical circuits, and the presence of compensatory mechanisms in
the surrounding cortical network, is required in order to determine
the potential success of such a therapy.
In summary, in the current study we have identified that TDP-
43A315T reduces GluR1 at the postsynapse and attenuates the intrinsic
excitability of cortical pyramidal neurons, providing a link between
the pathological effect of TDP-43 mutation and attenuated neuronal
synaptic function. Identification of the timing of neuronal
hypoexcitability within ALS patient disease progression, the exact
mechanisms by which mutant TDP-43 lowers synaptic GluR1, and
modulation of synaptic GluR1 levels, may provide novel therapeutic
targets for the treatment of this devastating neurodegenerative disease.
MATERIALS AND METHODS
Ethical statement
All experiments performed on animals were approved by the University of
Tasmania Animal Ethics Committee (A0014118) and conducted according
to the Australian Code of Practice for the care and use of animals for
scientific purposes. Animals were bred at the University of Tasmania’s
animal facility and housed in individually ventilated cages in a temperature-
controlled environment, with a 12-h light/dark cycle and access to food and
water ad libitum.
Transgenic mice
Thy1-YFP-16 transgenic mice (JAX 003709; The Jackson Laboratory)
express cytosolic YFP under the control of the pyramidal/projection-neuron-
specific Thy-1 promoter (Feng et al., 2000). Prp-TDP-43A315T transgenic
mice (JAX 010700; The Jackson Laboratory) express hTDP-43 with a 315
A-T substitution mutation (TDP-43A315T) (Wegorzewska et al., 2009;
Herdewyn et al., 2014). These two transgenic mouse lines were time-mated
to generate YFP:TDP-43A315T transgenic embryos and YFP:WT controls.
Primary neuronal culture
Primary dissociated cortical neuron cultures from mouse embryos were
prepared as previously described (Blizzard et al., 2013; Brizuela et al., 2017;
Brizuela et al., 2015). Briefly, Thy1-YFP-16 female mice that had been
time-mated with male Prp-TDP-43A315T mice were euthanized by CO2
exposure at 15.5 days of gestation. Embryos were genotyped for YFP-
transgenic status by fluorescent imaging using 470 nm light on a Carestream
Image Station 4000MMPro (CarestreamMolecular Imaging). YFP-positive
embryos were used to generate three biological replicates for cortical neuron
Fig. 6. The effect of TDP-43A315T expression
on neuronal excitability. (A,B) Phase image
of a TDP-43A315T cortical neuron (A) that is YFP
positive (B, green) selected for whole-cell patch
clamp analysis at 10 DIV. Passive membrane
parameters of YFP:WT and YFP:TDP-43A315T
cortical neurons were analyzed. (C-E) There were
no significant differences in resting membrane
potential (C), capacitance (D) and input resistance
(E) betweenWTand TDP-43A315T cortical neurons.
(F) There was a significant increase in
depolarization threshold in the TDP-43A315T
cortical neurons in comparison to WT controls.
(G,H) There were no significant differences in
peak inward (G) or peak outward (H) current.
(I) Representative traces of WT and TDP-43A315T
patched neurons (left). Using a series of
depolarizing current steps (100 to 500pA, in
25 pA increments, 200 ms duration), the
( f-I) relationship generated indicated that the
TDP-43A315T neurons fired at lower rates for a
given current compared to WT neurons (right).
n=3 biological replicates. *P<0.05 (Student’s t-test).
Data are mean±s.e.m. Scale bar: 20 μm.
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culture, and tails from the respective embryos were kept for TDP-43A315T
genotyping. The top layer of the cortex was removed from single embryos
and dissociated by 5 min enzymatic digestion at 37°C (0.025% w/v trypsin
in 5 ml Hank’s Buffered Salt Solution; both Thermo Fisher Scientific),
which was halted by the addition of 1 ml of pre-warmed initial medium
(Neurobasal supplemented with 2% v/v B27, 10% v/v fetal calf serum,
0.5 mM L-glutamine, 25 μM glutamic acid and 1% v/v antibiotic-
antimycotic; Thermo Fisher Scientific). Cells were triturated and cell
viability and concentration were assessed using Trypan Blue vital dye
exclusion. Cells were plated into 24-well plates, which contained coverslips
that had been pre-coated with 0.001% poly-L-lysine (Sigma-Aldrich) in
0.01 M PBS, or into 6-well plates and kept in a humidified incubator at 37°C
and 5%CO2. At 1 DIV, initial mediumwas replaced with serum-free growth
medium (Neurobasal supplemented with 2% v/v B27, 0.5 mML-glutamine,
1% v/v antibiotic-antimycotic); after that, ∼50% of the medium was
replaced every 2-3 days. All reagents were authenticated and tested for
contamination. No randomization was performed; however, it was ensured
that multiple single cell cultures were used from a minimum of three
different litters.
TDP-43A315T genotyping
REDExtract-N-Amp Tissue PCR Kit (Sigma-Aldrich) was used to isolate
total DNA from tails. Primer sequences were: hTDP-43 forward GGATG-
AGCTGCGGGAGTTCT, reverse TGCCCATCATACCCCAACTG; and
T-cell receptor alpha/delta (DNA control gene) forward CAAATGTTGC-
TTGTCTGGTG, reverse GTCAGTCGAGTGCACAGTTT. PCR products
were separated on a 1.5% agarose gel and visualized under UV light
(Carestream Image Station).
Immunocytochemistry and morphological analyses
Cultures at 3 DIV, 5 DIV, 10 DIV and 15 DIV were fixed in 4% w/v
paraformaldehyde in PBS before immunolabeling. Primary antibodies (see
Table S1) were diluted in 0.3% v/v Triton X-100 (Sigma-Aldrich) in PBS
(except for NT-GluR1 and NT-GluR2, which were diluted in PBS without
Triton X-100), and applied for 1 h at room temperature followed by
overnight incubation at 4°C. Coverslips were washed thrice in PBS before
the application of isotype- and species-specific secondary antibodies (see
Table S1), diluted 1:1000 in 0.01 M PBS and applied to coverslips for 1.5 h
at room temperature. Coverslips were washed thrice with PBS before
mounting in fluorescent mounting medium (Thermo Fisher Scientific).
Immunolabeling was visualized and imaged using an UltraView spinning-
disc confocal microscope with Velocity Software (Perkin Elmer).
For dendrite structure analysis, cells in confocal immunolabeled images
were traced using Neurolucida software (MBF Bioscience). Branched
structure analysis was used to analyze the length, the branching number and
the number of primary, secondary, tertiary and quaternary order dendrites of
MAP2-labeled neurons. Dendrites were traced and spines were marked on
YFP-positive neurons, with tracings exported to Neurolucida Explorer 11
(MBF Bioscience) for spine quantification. The spine analysis was
performed by an investigator blinded to genotype.
Quantitation of colocalization
Primary cortical neurons fixed at 10 DIVwere used to investigate expression
and localization of synaptic proteins. Postsynaptic receptors and
synaptophysin (for antibodies see Table S1) were immunolabeled then
imaged using an UltraView spinning-disc confocal microscope. The ratio of
receptor expression to YFP was analyzed using the ImageJ colocalization
plugin (Schindelin et al., 2012), and the ratio for WT neurons was
normalized to 1 for analysis.
Electrophysiology
At 10 DIV, cortical neurons that had been cultured on glass coverslips were
superfused at 24±1°C with bicarbonate-buffered solution (155 mM NaCl,
3.5 mM KCl, 2 mM CaCl2, 1.5 mM MgCl2, 10 mM glucose; osmolarity
adjusted to 305-310 mOsm/kg by the addition of D-sorbitol; all Sigma-
Aldrich). Patch electrodes formed from borosilicate glass capillaries
(1.5 mm outer diameter ×0.86 mm inner diameter) (Harvard Apparatus)
with a resistance of 7-9 MΩ were filled with a solution containing 130 mM
K-gluconate, 4 mM NaCl, 10 mM HEPES, 0.5 mM CaCl2, 10 mM
BAPTA, 4 mM MgATP, 0.5 mM Na2GTP 0.5 (pH 7.4, set with KOH)
and osmolarity adjusted to 290 mOsm/kg with D-sorbitol. An Axopatch
200B amplifier (Molecular Devices) was used for voltage- and current-
clamp. Data was adjusted to account for the electrode-junction potential.
Datawere sampled at 10 kHz and filtered at 5 Hz using pClamp 9.2 software
(Molecular Devices), and offline analysis was performed using Igor
(WaveMetrics) and Axograph.
Nuclear and cytoplasmic protein extraction
Nuclear and cytoplasmic protein was extracted using a NE-PERNuclear and
Cytoplasmic Extraction Reagents kit (Thermo Fisher Scientific). Briefly,
cortical cultures (6×105 cells) were grown on 6-well plate to 15 DIV. At
15 DIV, cells were removed from the plate using a cell scraper, in PBS, and
then centrifuged at 500 g for 5 min. Cells were resuspended in PBS
and transferred (2×106) to a 1.5 ml microcentrifuge tube and repelleted at
500 g for 2-3 min. Cytoplasmic and nuclear extract was isolated as per
the protocol.
Western blotting
Protein concentration of nuclear and cytoplasmic protein fractions was
determined using the DC Protein Assay (Bio-Rad). Nuclear and/or
cytoplasmic fractions were solubilized in Laemmli buffer (Bio-Rad) with
5% β-mercaptoethanol (Bio-Rad) and separated by size using NuPAGE 4-
12% Bis-Tris gels with MES SDS running buffer, alongside PageRuler Plus
pre-stained protein ladder (all Life Technologies). Proteins were transferred
to PVDF membrane using NuPAGE transfer buffer (Life Technologies)
with 10% ethanol (Sigma-Aldrich). Membranes were blocked using 5%w/v
non-fat milk powder in Tris-buffered saline with 0.05% Tween-20 (Sigma-
Aldrich) (TBS-T), then incubated with primary antibodies overnight at 4°C
(Table S1), washed in TBS-T, incubated for 1 h with secondary antibody at
room temperature (Table S1) and washed in TBS-T. Membranes were then
imaged using Amersham Imager 600 (GE Lifesciences) with Immobilon
chemiluminescence substrate (Millipore). Membranes were sequentially re-
probed after incubation in Restore PLUS Western Blot Stripping Buffer
(Thermo Fisher Scientific). Quantification of western blot bands was
performed with integrated density values obtained using ImageJ.
Axonal outgrowth analysis
Cortical neurons (5×105 cells) were plated into the somal compartment
of microfluidic chambers (Southam et al., 2013) on square coverslips
pre-coated with 0.001% poly-L-lysine. At 6 DIV, time-lapse images of
the microfluidic chamber axonal compartment were obtained (one image
every 2 min for 30 min) using a Nikon TiE motorized inverted microscope
with ×40/0.95 objective (Nikon Instruments). Axon outgrowth and
path length were calculated using NIS-Elements AR 3.2 software
(Nikon Instruments).
Statistical analysis
All statistical analysis was performed in GraphPad Prism (GraphPad
Software) using t-tests and one-way or two-way ANOVA with Tukey’s
post-hoc correction for multiple comparisons. P<0.05 was considered
significant. Data is reported as mean±s.e.m. Where appropriate, the person
performing the neurite and dendrite spine tracing was blinded to genotype.
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